David G. Kelly

Insider Reports History

Entity
Individual
Location
C/O Horizon Pharma Plc, Adelaide Chambers, Peter Street, Dublin 8, Ireland
Signature
/s/ David G. Kelly
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David G. Kelly:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Iterum Therapeutics plc Director Stock Option (Right to Buy) 64.7K $52.4K $0.81 Jun 23, 2021 Direct
Iterum Therapeutics plc Director Share Option (Right to Buy) 647K Jun 15, 2022 Direct

Insider Reports Filed by David G. Kelly

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ITRM Iterum Therapeutics plc Jun 15, 2022 1 $0 4 Jun 17, 2022 Director
ITRM Iterum Therapeutics plc Jun 23, 2021 1 $0 4 Jun 25, 2021 Director